CLS Holdings USA, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Commitments and Contingencies (Details)

Commitments and Contingencies (Details)																				3 Months Ended	6 Months Ended		9 Months Ended	12 Months Ended
Commitments and Contingencies (Details)	Oct. 14, 2019 USD ($)	Jul. 22, 2019 shares	Jul. 19, 2019 USD ($)	May 14, 2019	Apr. 08, 2019 USD ($) shares	Mar. 01, 2019 USD ($) shares	Aug. 01, 2018	Jul. 31, 2018 USD ($) shares	Jul. 01, 2018 USD ($) shares	Apr. 06, 2018 USD ($)	Jan. 05, 2018 USD ($)	Nov. 30, 2017 USD ($) shares	Oct. 09, 2017 USD ($)	Aug. 23, 2017 USD ($)	Jul. 20, 2016 USD ($)	Mar. 31, 2016 USD ($)	Aug. 01, 2015 USD ($) shares	Oct. 14, 2014 USD ($)	Oct. 01, 2014 USD ($)	Aug. 31, 2018 shares	Nov. 30, 2019 USD ($)	Nov. 30, 2018 USD ($)	Feb. 28, 2019 USD ($)	May 31, 2019 USD ($)	Apr. 17, 2017 ft²
Commitments and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision																							$ 10,000
Debt Conversion, Original Debt, Amount			$ 12,542																		$ 25,857	$ 0		$ 13,315
Share-based Payment Arrangement, Expense																					93,902	230,888
Employee-related Liabilities, Current																					205,301			$ 230,119
Chief Executive Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Employment Agreement, Term																			5 years
Salary and Wage, Officer, Excluding Cost of Good and Service Sold									$ 150,000									$ 200,000	$ 150,000
Deferred Compensation Arrangement with Individual, Description									performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of the annual EBITDA										performance bonus equal to 2% of CLS Labs’ annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Share-based Compensation Arrangement by Share-based Payment Award, Description																			annual stock options, exercisable at the fair market value of CLS Labs’ common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Employment Agreement, Amendment																		the amendment provides for certain change of control provisions, including a payment of up to three years base salary and bonuses up to a maximum of $1,000,000, if Mr. Binder resigns or is terminated in connection with a change in control of the Company
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period									1 year
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) \| shares		500,000
Chief Operating Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Employment Agreement, Term				2 years													5 years
Salary and Wage, Officer, Excluding Cost of Good and Service Sold								$ 150,000									$ 150,000
Deferred Compensation Arrangement with Individual, Description								performance bonus equal to 2% of the annual EBITDA of CLS Nevada, Inc., and annual restricted stock awards of the Company’ common stock in an amount equal to 3% of the annual EBITDA									performance bonus equal to 2% of the Company’s annual EBITDA, up to a maximum annual cash compensation of $1 million (including his base salary), and annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Share-based Compensation Arrangement by Share-based Payment Award, Description																	annual stock options, exercisable at the fair market value of the Company’s common stock on the date of grant, in an amount equal to 2% of its annual EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period									1 year
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) \| shares		50,000
President and Chief Financial Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Salary and Wage, Officer, Excluding Cost of Good and Service Sold												$ 175,000
Deferred Compensation Arrangement with Individual, Description												performance bonus equal to 2% of the Company’s annual EBITDA, and annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA
Share-based Compensation Arrangement by Share-based Payment Award, Description												annual restricted stock awards of the Company’s common stock in an amount equal to 3% of its annual EBITDA
Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture (in Shares) \| shares																				600,000
President [Member]
Commitments and Contingencies (Details) [Line Items]
Salary and Wage, Officer, Excluding Cost of Good and Service Sold	$ 200,000					$ 175,000
Deferred Compensation Arrangement with Individual, Description	performance-based bonus equal to two percent (2%) of the Company’s annual EBITDA up to a maximum annual cash compensation of $1 million including base salary, and annual stock options, exercisable at the fair market value of the Company’s common stock on the effective date of grant, in an amount equal to 2% of the Company’s EBITDA up to $42.5 million and 4% of its annual EBITDA in excess of $42.5 million					performance bonus equal to 1% of the Company’s annual EBITDA, and annual restricted stock awards in an amount equal to 1% of the Company’s annual EBITDA
Employment Agreement, Amendment	the amendment provides for certain change of control provisions, including a payment of up to three years base salary and bonuses up to a maximum of $1,000,000, if Mr. Glashow resigns or is terminated in connection with a change in control of the Company
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares						500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period						1 year
Chief Financial Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Salary and Wage, Officer, Excluding Cost of Good and Service Sold					$ 110,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period							4 months
Former Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Employee-related Liabilities, Current																					$ 16,250	$ 16,250
Building [Member]
Commitments and Contingencies (Details) [Line Items]
Area of Real Estate Property (in Square Feet) \| ft²																									14,392
Lessee, Operating Lease, Term of Contract																									72 months
Lessee, Operating Lease, Renewal Term																									10 years
Unpaid Accrued Salary Converted to Convertible Note [Member] \| Convertible Debt [Member] \| Chief Executive Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Debt Conversion, Original Debt, Amount										$ 37,500	$ 37,500		$ 39,521	$ 62,500	$ 250,000	$ 112,500
Deposit [Member]
Commitments and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision																							50,000
Rent Expense [Member]
Commitments and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision																							15,699
Remaining Amounts Due Under Lease [Member]
Commitments and Contingencies (Details) [Line Items]
Loss Contingency Accrual, Provision																							$ 30,000
One Time Signing Bonus [Member] \| Chief Executive Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares									500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period									1 year
One Time Signing Bonus [Member] \| Chief Operating Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares								50,000									250,000
Share-based Payment Arrangement, Expense																	$ 327,500
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period								1 year									1 year
One Time Signing Bonus [Member] \| President and Chief Financial Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares												500,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period												1 year
One Time Signing Bonus [Member] \| Chief Financial Officer [Member]
Commitments and Contingencies (Details) [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period (in Shares) \| shares					50,000
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period					1 year